Literature DB >> 17967844

Fatigue in multiple sclerosis: relation to depression, physical impairment, personality and action control.

I-K Penner1, N Bechtel, C Raselli, M Stöcklin, K Opwis, L Kappos, P Calabrese.   

Abstract

Although fatigue is one of the most common symptoms of multiple sclerosis, it is yet poorly understood and therefore difficult to manage. To clarify the nature of fatigue we investigated its relationship to depression, physical impairment, personality and action control and compared these variables between a sample of 41 MS patients and 41 healthy controls. Physical impairment was assessed by the EDSS and all other dimensions, using questionnaires. Stepwise linear regression analyses revealed that physical impairment was related to physical fatigue in MS patients. Depression was the main factor influencing fatigue among both, MS patients and controls. What clearly differentiated the two groups was the correlation between fatigue and action control. Decreased levels of action control imply attentional and motivational deficits and were only found in fatigued MS patients. Our study indicates that motivational disturbances might be specific for MS related fatigue.

Entities:  

Mesh:

Year:  2007        PMID: 17967844     DOI: 10.1177/1352458507079267

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  27 in total

1.  Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.

Authors:  Lindsay I Berrigan; John D Fisk; Scott B Patten; Helen Tremlett; Christina Wolfson; Sharon Warren; Kirsten M Fiest; Kyla A McKay; Ruth Ann Marrie
Journal:  Neurology       Date:  2016-03-09       Impact factor: 9.910

2.  Fatigue in spinocerebellar ataxia: patient self-assessment of an early and disabling symptom.

Authors:  Esther Brusse; Marjolein G J Brusse-Keizer; Hugo J Duivenvoorden; John C van Swieten
Journal:  Neurology       Date:  2011-03-15       Impact factor: 9.910

3.  Validation of a new quality of life scale related to multiple sclerosis and relapses.

Authors:  Antoine Baroin; Gilles Chopard; Gaye Siliman; Clément Michoudet; Aurore Vivot; Chrystelle Vidal; Hassna Mokadym; Annick Lavier; Eric Berger; Lucien Rumbach; Nathalie Rude
Journal:  Qual Life Res       Date:  2012-12-18       Impact factor: 4.147

Review 4.  Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe disease.

Authors:  J M de Vries; M L C Hagemans; J B J Bussmann; A T van der Ploeg; P A van Doorn
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

5.  Fatigue and physical disability in patients with multiple sclerosis: a structural equation modeling approach.

Authors:  Yvonne Bol; Annelien A Duits; Richel Lousberg; Raymond M M Hupperts; Michelle H P Lacroix; Frans R J Verhey; Johan W S Vlaeyen
Journal:  J Behav Med       Date:  2010-05-28

6.  Hip flexor fatigue limits walking in Charcot-Marie-Tooth disease.

Authors:  Gita M Ramdharry; Brian L Day; Mary M Reilly; Jonathan F Marsden
Journal:  Muscle Nerve       Date:  2009-07       Impact factor: 3.217

7.  Lower physical activity is associated with higher disease burden in pediatric multiple sclerosis.

Authors:  Stephanie A Grover; Berengere Aubert-Broche; Dumitru Fetco; D Louis Collins; Douglas L Arnold; Marcia Finlayson; Brenda L Banwell; Robert W Motl; E Ann Yeh
Journal:  Neurology       Date:  2015-08-12       Impact factor: 9.910

Review 8.  Is personality profile a relevant determinant of fatigue in multiple sclerosis?

Authors:  Herbert Schreiber; Michael Lang; Kristina Kiltz; Charlotte Lang
Journal:  Front Neurol       Date:  2015-02-04       Impact factor: 4.003

9.  A preliminary path analysis: Effect of psychopathological symptoms, mental and physical dysfunctions related to quality of life and body mass index on fatigue severity of Iranian patients with multiple sclerosis.

Authors:  Ghasem Salehpoor; Mozaffar Hosseininezhad; Sajjad Rezaei
Journal:  Iran J Neurol       Date:  2012

10.  Muscle-Derived IL-6 Is Not Regulated by IL-1 during Exercise. A Double Blind, Placebo-Controlled, Randomized Crossover Study.

Authors:  Thierry M Nordmann; Eleonora Seelig; Katharina Timper; Mareike Cordes; Michael Coslovsky; Henner Hanssen; Arno Schmidt-Trucksäss; Marc Y Donath
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.